Burn and Scald Medicine Industry Analysis：the global market size is projected to reach USD 0.6 billion by 2030

According to the new market research report “Burn and Scald Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”, published by QYResearch, the global Burn and Scald Medicine market size is projected to reach USD 0.6 billion by 2030, at a CAGR of 3.9% during the forecast period.

• Global Burn and Scald Medicine MarketSize(US$ Million), 2020-2031

Source: QYResearch, "Burn and Scald Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

• Global Burn and Scald Medicine Top31Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)

Source: QYResearch, "Burn and Scald Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

According to QYResearch Top Players Research Center, the global key manufacturers of Burn and Scald Medicine include Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, etc. In 2023, the global top five players had a share approximately 43.0% in terms of revenue.

According to QYResearch Top Players Research Center, the global key manufacturers of Burn and Scald Medicine include Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, Yangtze River Pharmaceutical Group, STADA Thornton & Ross, Kenvue Brands LLC, Changchun Overseas Pharmaceutical Group Co., Ltd., Orkla Health, etc. In 2023, the global top 10 players had a share approximately 49.0% in terms of revenue.

The increasing aging of the population has increased the proportion of burns and scalds caused by accidents such as falls and scalds among the elderly, thus driving the demand for the burn and scald drug market. The frequent occurrence of industrial accidents and the accelerated pace of life have also increased the incidence of burns and scalds, further expanding the market demand.

The continuous advancement of medical technology, especially the application of biotechnology and nanotechnology in burn treatment, has brought new development opportunities to the burn and scald drug industry.

The research and development of new drugs, such as growth factors and skin regeneration factors, have provided new treatment methods for burn and scald treatment, improved the treatment effect, and met the diverse needs of patients.

The state has issued a series of policies and regulations for the field of burn and scald drugs, aiming to regulate the market order and ensure the safety of patients' medication. These regulations provide legal protection for the burn and scald drug industry and promote the healthy development of the industry.

Policy support and supervision guide enterprises to increase R&D investment, promote the development of new drugs, promote industrial upgrading, and bring more development opportunities to the industry.

Favorable measures of the government, such as compensation policies covering almost 70-100% of treatment costs, enable patients to choose advanced burn care treatment. The presence of governmental organizations, such as the World Health Organization (WHO), and non-profit organizations, such as the American Burn Association (ABA), have also helped to raise awareness levels. WHO has been working with the International Society for Burn Injuries and other such organizations to develop strategies to improve burn care worldwide and prevent such injuries. Non-profit organizations that aim to provide and disseminate knowledge about optimal treatment and rehabilitation after burns, such as the British Burn Association and the Canadian Burn Nurses Association, are also raising awareness levels.

About The Authors

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp